{"id":"W4414299453","doi":"10.1016/j.ard.2025.08.006","title":"Inhibition of structural damage progression with the selective interleukin-23 inhibitor guselkumab in participants with active PsA: results through week 24 of the phase 3b, randomised, double-blind, placebo-controlled APEX study","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"Johnson and Johnson","keywords":"Monoclonal antibody; Apex (geometry); Phases of clinical research; Monoclonal; Antibody; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003209755,0.001211443,0.002315334,0.00028376,0.0003332705,0.0007787317,0.0008256178,0.001389905,0.004921955],"category_scores_gemma":[0.001656551,0.0005323605,0.001804998,0.0003268319,0.0007035361,0.0007479343,0.0003868915,0.002532059,0.0007859033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003555006,"about_ca_system_score_gemma":0.001146779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004513031,"about_ca_topic_score_gemma":0.001150475,"domain_scores_codex":[0.9991053,0.0004545269,0.00006488535,0.0001217502,0.0001291777,0.0001242259],"domain_scores_gemma":[0.998781,0.0002690438,0.0003194928,0.00009114163,0.0001689915,0.0003704355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9388143,0.009608085,0.002363016,0.00113306,0.001591549,0.00005520535,0.0001446414,0.0002718052,0.01318772,0.0000671524,0.001023953,0.03173945],"study_design_scores_gemma":[0.7268098,0.2471075,0.02001948,0.00009675397,0.001615067,0.0000901032,0.00007545238,0.0003501583,0.002221667,0.000137728,0.001444459,0.00003176226],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883908,0.007066388,0.0006184648,0.0002873057,0.0001639883,0.001430686,0.001006301,0.00007918649,0.0009568507],"genre_scores_gemma":[0.9910508,0.003018668,0.001142166,0.0005277909,0.0002432073,0.00155996,0.0008094534,0.00002627238,0.001621631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004921955,"threshold_uncertainty_score":0.01697499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04782480471194316,"score_gpt":0.3638871782904056,"score_spread":0.3160623735784625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}